Stay in the Loop

Get the latest expert reviews and gear recommendations delivered to your inbox.

Ekso Bionics vs ReWalk: Which Powered Exoskeleton Is Better for Elderly Patients?

Clinical comparison of EksoNR powered exoskeleton and ReWalk Personal 6.0 in rehabilitation setting for elderly patients

Both names appear in clinical trial after clinical trial. Both have FDA clearance. Both cost more than most cars. The question — which is better for elderly patients in the Ekso Bionics vs ReWalk comparison — doesn’t have a simple answer. But it does have a structured one.

What Are We Comparing?

The Ekso EksoNR (Ekso Bionics) is a powered robotic exoskeleton designed for neurological rehabilitation — stroke, SCI, MS, TBI. Used with physiotherapist supervision in a clinical setting. Approximately $150,000 per unit. The ReWalk Personal 6.0 (ReWalk Robotics) is FDA-cleared for home and community use by SCI patients, and increasingly used in stroke rehabilitation. Requires forearm crutches and strong upper-body function. Approximately $80,000 per unit.

Head-to-Head Specifications

SpecificationEkso EksoNRReWalk Personal 6.0
Primary indicationStroke, SCI, MS, TBISCI (FDA-cleared); stroke (off-label)
SettingClinical (with therapist)Home + community use
FDA clearanceYes (clinical use)Yes (home use for SCI)
Device weight23 kg23.3 kg
Battery runtime4–6 hours~3 hours
Upper-body requirementLow (therapist supports)High (crutches required)
Price (approx.)~$150,000~$80,000

EksoNR: For Clinical Rehabilitation Programmes

The Ekso EksoNR is optimised for the clinical rehabilitation environment. Its adaptive assist technology adjusts support to the patient’s available motor capacity in real time, making it appropriate for patients with highly variable function across sessions — common in early post-stroke or post-SCI rehabilitation. The therapist operates the device and the patient does not need upper-body strength to use it.

For elderly patients with stroke or neurological diagnoses, the EksoNR is the device of choice when the goal is clinical rehabilitation outcomes. It is not a home device. Access is through specialist rehabilitation units. For related clinical context, see our review of exoskeletons for Parkinson’s disease gait training.

ReWalk Personal 6.0: For Home and Community Independence

The ReWalk Personal 6.0 is the only powered exoskeleton FDA-cleared for home and community use. It enables SCI patients to stand, walk, and navigate real-world environments independently. The critical requirement: users must have sufficient upper-body strength to manage forearm crutches safely. For elderly patients with significant upper-body weakness, this is often the limiting factor.

ReWalk is the device to evaluate when the goal is home use independence rather than clinical rehabilitation. Medicare Advantage coverage for ReWalk in SCI is available through some plans — see our Medicare coverage guide for detail.

The Decision Framework for Elderly Patients

In the Ekso Bionics vs ReWalk comparison for elderly patients: choose EksoNR if the goal is clinical rehabilitation after neurological injury (stroke, SCI) and the patient has access to a specialist rehabilitation programme. Choose ReWalk if the goal is home and community independence, the patient has adequate upper-body function, and funding is available. For most elderly patients, the EksoNR is the appropriate clinical starting point — home use comes after demonstrated rehabilitation progress.

For broader context on choosing the right exoskeleton for a senior family member, see How to Choose an Exoskeleton for a Senior Parent and our Best Exoskeletons for Elderly 2026 guide.

Bottom Line

The Ekso Bionics vs ReWalk comparison is not a head-to-head competition — they serve different phases of rehabilitation. EksoNR is the clinical rehabilitation tool; ReWalk is the community independence tool. The appropriate choice depends on where in the rehabilitation pathway the patient is and what independence goal is being targeted.